14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:TSRO
Delisted

TESARO Fund Price (Quote)

$74.96
+0 (+0%)
At Close: Feb 13, 2019

Range Low Price High Price Comment
30 days $0.0060 $169.56 Wednesday, 13th Feb 2019 TSRO stock ended at $74.96. During the day the stock fluctuated 0% from a day low at $74.96 to a day high of $74.96.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical TESARO prices

Date Open High Low Close Volume
Sep 19, 2018 $35.75 $37.84 $35.75 $37.01 1 425 815
Sep 18, 2018 $35.65 $36.25 $35.08 $35.77 1 334 021
Sep 17, 2018 $34.65 $35.33 $33.40 $35.04 2 066 682
Sep 14, 2018 $34.79 $35.33 $34.17 $34.92 1 394 392
Sep 13, 2018 $35.23 $35.65 $34.34 $34.50 719 391
Sep 12, 2018 $35.09 $35.80 $34.50 $35.09 635 438
Sep 11, 2018 $36.12 $36.33 $34.23 $35.17 1 295 800
Sep 10, 2018 $35.83 $37.03 $35.53 $36.47 1 594 069
Sep 07, 2018 $34.30 $35.93 $34.25 $35.79 1 607 534
Sep 06, 2018 $35.40 $35.57 $34.04 $34.52 2 529 123
Sep 05, 2018 $35.61 $39.48 $33.75 $34.93 10 589 600
Sep 04, 2018 $32.44 $33.21 $31.14 $33.12 1 327 754
Aug 31, 2018 $32.25 $32.94 $31.87 $32.45 616 910
Aug 30, 2018 $32.50 $33.51 $32.22 $32.31 1 340 393
Aug 29, 2018 $31.35 $33.29 $31.18 $32.48 1 675 108
Aug 28, 2018 $32.00 $32.28 $30.97 $31.49 1 296 230
Aug 27, 2018 $30.25 $32.17 $30.02 $32.10 1 583 389
Aug 24, 2018 $30.88 $31.24 $29.78 $30.10 1 063 474
Aug 23, 2018 $31.40 $31.63 $30.04 $30.72 1 278 438
Aug 22, 2018 $30.98 $31.96 $30.58 $31.32 1 619 540
Aug 21, 2018 $28.69 $31.28 $28.69 $31.00 2 332 911
Aug 20, 2018 $28.58 $29.32 $28.07 $28.71 1 063 649
Aug 17, 2018 $27.31 $28.87 $27.00 $28.78 1 590 109
Aug 16, 2018 $27.46 $27.85 $26.93 $27.22 972 586
Aug 15, 2018 $27.34 $27.94 $27.01 $27.26 1 819 513
Click to get the best stock tips daily for free!

About TESARO

TESARO, Inc., an oncology-focused biopharmaceutical company, identifies, acquires, develops, and commercializes cancer therapeutics and oncology supportive care products in the United States and internationally. Its product portfolio consist of Rolapitant, a neurokinin-1 receptor antagonist, which is in phase 1 intravenous clinical trials for the prevention of chemotherapy induced nausea and vomiting; Niraparib, an orally active and potent poly p... TSRO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT